Literature DB >> 24170607

Is surgical intervention for cystic neoplasms of the pancreas being underutilized?

C Max Schmidt1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24170607     DOI： 10.1007/s11605-013-2396-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  5 in total

Review 1.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

2.  Outcomes of primary surveillance for intraductal papillary mucinous neoplasm.

Authors:  Christy E Cauley; Joshua A Waters; Ryan P Dumas; Juliana E Meyer; Mohammad A Al-Haddad; John M DeWitt; Keith D Lillemoe; C Max Schmidt
Journal:  J Gastrointest Surg       Date:  2011-11-17       Impact factor: 3.452

3.  Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm.

Authors:  Jacob R Miller; Juliana E Meyer; Joshua A Waters; Mohammad Al-Haddad; John Dewitt; Stuart Sherman; Keith D Lillemoe; C Max Schmidt
Journal:  HPB (Oxford)       Date:  2011-09-09       Impact factor: 3.647

4.  Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.

Authors:  C Max Schmidt; Patrick B White; Joshua A Waters; Constantin T Yiannoutsos; Oscar W Cummings; Marshall Baker; Thomas J Howard; Nicholas J Zyromski; Atilla Nakeeb; John M DeWitt; Fatih M Akisik; Stuart Sherman; Henry A Pitt; Keith D Lillemoe
Journal:  Ann Surg       Date:  2007-10       Impact factor: 12.969

5.  Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.

Authors:  H Uehara; A Nakaizumi; O Ishikawa; H Iishi; K Tatsumi; R Takakura; T Ishida; Y Takano; S Tanaka; A Takenaka
Journal:  Gut       Date:  2008-05-13       Impact factor: 23.059
  5 in total
  5 in total

1.  Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia.

Authors:  Michele T Yip-Schneider; Rosalie A Carr; Huangbing Wu; C Max Schmidt
Journal:  J Am Coll Surg       Date:  2017-07-21       Impact factor: 6.113

2.  Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.

Authors:  Rachel E Simpson; Michele T Yip-Schneider; Katelyn F Flick; Huangbing Wu; Cameron L Colgate; C Max Schmidt
Journal:  Pancreas       Date:  2019-09       Impact factor: 3.327

3.  Benign Tumors of the Pancreas-Radical Surgery Versus Parenchyma-Sparing Local Resection-the Challenge Facing Surgeons.

Authors:  Hans G Beger
Journal:  J Gastrointest Surg       Date:  2018-01-03       Impact factor: 3.452

4.  National trends in resection of cystic lesions of the pancreas.

Authors:  Bradley N Reames; Christopher P Scally; Timothy L Frankel; Justin B Dimick; Hari Nathan
Journal:  HPB (Oxford)       Date:  2016-02-09       Impact factor: 3.647

5.  The changing spectrum of surgically treated cystic neoplasms of the pancreas.

Authors:  Jennifer K Plichta; Jacqueline A Brosius; Sam G Pappas; Gerard J Abood; Gerard V Aranha
Journal:  HPB Surg       Date:  2015-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.